Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Glucocorticoid induced osteoporosis].

R Gutiérrez-Polo1

  • 1Sección de Reumatología, Hospital de Navarra, Pamplona, 31008, Spain. ricardoagp@yahoo.es

Anales Del Sistema Sanitario De Navarra
|January 13, 2004
PubMed
Summary

Glucocorticoids can cause secondary osteoporosis, a major health issue leading to fractures. Early, multidisciplinary management is crucial, but new treatments are needed to mitigate adverse effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

[Subacute meningoencephalitis following intravesical BCG instillation immunotherapy].

Anales del sistema sanitario de Navarra·2026
Same journal

[Treatment with dabrafenib and trametinib in an intrahepatic cholangiocarcinoma harboring a BRAF V600E mutation].

Anales del sistema sanitario de Navarra·2026
Same journal

[Efficiency after integrating a hospital with a 'new management model'].

Anales del sistema sanitario de Navarra·2026
Same journal

[Anales del Sistema Sanitario de Navarra in 2025: Progress continues].

Anales del sistema sanitario de Navarra·2026
Same journal

Qualitative evaluation of a community intervention in educational centres: Opinion of the professionals involved.

Anales del sistema sanitario de Navarra·2026
Same journal

[Unequal impact of COVID-19 on mortality in long-term care homes across health areas of Castilla-La Mancha (Spain)].

Anales del sistema sanitario de Navarra·2026

Area of Science:

  • Endocrinology and Bone Metabolism
  • Pharmacology
  • Rheumatology

Context:

  • Glucocorticoids are essential medications with significant therapeutic utility.
  • Long-term systemic use of glucocorticoids is a leading cause of secondary osteoporosis.
  • This condition results in substantial health and socio-economic burdens due to fragility fractures and functional impairment.

Purpose:

  • To highlight the significant adverse event of corticoid-induced osteoporosis.
  • To emphasize the multifactorial pathogenesis, particularly the inhibition of bone formation by glucocorticoids.
  • To underscore the suboptimal current management and the need for improved strategies.

Summary:

  • Bone loss occurs early in glucocorticoid therapy, correlating with dosage.
  • Effective management requires a proactive, multidisciplinary approach, starting at therapy initiation.
  • Current recommendations for diagnosis, prevention, and treatment are similar to other osteoporosis causes but require specific considerations for corticosteroid self-management.

Impact:

  • Corticoid-induced osteoporosis causes significant morbidity, including vertebral fractures and functional disability.
  • There is a critical need for enhanced diagnostic, preventive, and therapeutic strategies.
  • Further research into novel treatments is essential to minimize adverse consequences and improve patient outcomes.

Related Experiment Videos